| Nov 7 |
Edgewise Therapeutics reports Q3 results
|
| Nov 7 |
Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
|
| Oct 7 |
Edgewise Therapeutics, Inc. (EWTX): A Hot Stock to Buy Now
|
| Oct 1 |
Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society
|
| Sep 22 |
Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
|
| Sep 20 |
Novo sinks on obesity drug results; Sanofi reveals anticipated MS data
|
| Sep 20 |
Company News for Sep 20, 2024
|
| Sep 20 |
Edgewise’s EDG-7500 shows benefit in two obstructive HCM trials
|
| Sep 19 |
Edgewise: Stock Is Bouncing On Heart Disease Drug Data, Albeit From Just 7 Patients (Rating Upgrade)
|
| Sep 19 |
Why Edgewise Therapeutics Stock Is Up 50% on Thursday
|
